{"id":798321,"date":"2025-01-07T07:06:02","date_gmt":"2025-01-07T12:06:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\/"},"modified":"2025-01-07T07:06:02","modified_gmt":"2025-01-07T12:06:02","slug":"adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\/","title":{"rendered":"ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">RAMSEY, N.J. and BOCA RATON, Fla., Jan.  07, 2025  (GLOBE NEWSWIRE) &#8212; ADMA Biologics, Inc. (Nasdaq: ADMA) (\u201cADMA\u201d or the \u201cCompany\u201d), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced that Company management will present at the 43rd Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 13-16, 2025. ADMA\u2019s presentation will be on Monday, January 13, 2025, at 10:30 a.m. PT.<\/p>\n<p>A live audio webcast of the call will be available under \u201cEvents &amp; Webcasts\u201d in the investor section of the Company\u2019s website, https:\/\/ir.admabiologics.com\/events-webcasts. An archived webcast will be available on the Company\u2019s website approximately two hours after the event.<\/p>\n<p align=\"justify\">\n        <strong>About ADMA Biologics, Inc. (ADMA)<\/strong>\n      <\/p>\n<p align=\"justify\">ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. ADMA currently manufactures and markets three United States Food and Drug Administration (FDA)-approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: BIVIGAM<sup>\u00ae<\/sup> (immune globulin intravenous, human) for the treatment of primary humoral immunodeficiency (PI); ASCENIV\u2122 (immune globulin intravenous, human \u2013 slra 10% liquid) for the treatment of PI; and NABI-HB<sup>\u00ae<\/sup> (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. ADMA manufactures its immune globulin products at its FDA-licensed plasma fractionation and purification facility located in Boca Raton, Florida. Through its ADMA BioCenters subsidiary, ADMA also operates as an FDA-approved source plasma collector in the United States, which provides its blood plasma for the manufacture of its products. ADMA\u2019s mission is to manufacture, market and develop specialty biologics and human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient populations who suffer from an underlying immune deficiency, or who may be immune compromised for other medical reasons. ADMA holds numerous U.S. and foreign patents related to and encompassing various aspects of its products and product candidates. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4O29bg6msmyacWXQf2N2Q70Bo-79Hrt2xwo0xAbQl5dIX8tNoC3FrrzLjIPSYdo4LjlcwqEEGVGXXAMVo_mUgspM36_usyV5rnqZSRX_yhiqCXghLs6qK5HR7Gy-x33r-YN12-1p_2hU_ZsmXlWlT24LpbweERzeD_sb9_NVNfIHpOgED32q8WSFpVLytWlKlWehVE1ERK7gJvQUxWfQiktFTRr8heLEuB3x53cfaeQWLfFsReh5Q8QJ-8K-WFCw3iQRq7wd__l8ugV139b8qg==\" rel=\"nofollow\" target=\"_blank\"><strong><u>www.admabiologics.com<\/u><\/strong><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>INVESTOR RELATIONS CONTACT:<\/strong><br \/>\n        <br \/>Argot Partners | 212-600-1902 | <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WWPuwpNAgjiDHYZ3R19PEbjaG27yMhhXX1yAjL6MIKYI_qel3MCFzDFUo4M3QVkHEglJ5Ro5dPxwdKG4CtaCk8dVbcLDoBFBa6-v6EBkCcI=\" rel=\"nofollow\" target=\"_blank\">ADMA@argotpartners.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzQ1OSM2NjgwMzE4IzIwMjM3MzA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YTU2YWZkYmItOGM2Yi00N2I2LTgzZDQtZTAxYWEyMmZkMTg4LTEwMzUyOTc=\/tiny\/ADMA-Biologics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>RAMSEY, N.J. and BOCA RATON, Fla., Jan. 07, 2025 (GLOBE NEWSWIRE) &#8212; ADMA Biologics, Inc. (Nasdaq: ADMA) (\u201cADMA\u201d or the \u201cCompany\u201d), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced that Company management will present at the 43rd Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 13-16, 2025. ADMA\u2019s presentation will be on Monday, January 13, 2025, at 10:30 a.m. PT. A live audio webcast of the call will be available under \u201cEvents &amp; Webcasts\u201d in the investor section of the Company\u2019s website, https:\/\/ir.admabiologics.com\/events-webcasts. An archived webcast will be available on the Company\u2019s website approximately two hours after the event. About ADMA Biologics, Inc. (ADMA) ADMA Biologics is an end-to-end &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-798321","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"RAMSEY, N.J. and BOCA RATON, Fla., Jan. 07, 2025 (GLOBE NEWSWIRE) &#8212; ADMA Biologics, Inc. (Nasdaq: ADMA) (\u201cADMA\u201d or the \u201cCompany\u201d), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced that Company management will present at the 43rd Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 13-16, 2025. ADMA\u2019s presentation will be on Monday, January 13, 2025, at 10:30 a.m. PT. A live audio webcast of the call will be available under \u201cEvents &amp; Webcasts\u201d in the investor section of the Company\u2019s website, https:\/\/ir.admabiologics.com\/events-webcasts. An archived webcast will be available on the Company\u2019s website approximately two hours after the event. About ADMA Biologics, Inc. (ADMA) ADMA Biologics is an end-to-end &hellip; Continue reading &quot;ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-07T12:06:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzQ1OSM2NjgwMzE4IzIwMjM3MzA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025\",\"datePublished\":\"2025-01-07T12:06:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\\\/\"},\"wordCount\":375,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNzQ1OSM2NjgwMzE4IzIwMjM3MzA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\\\/\",\"name\":\"ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNzQ1OSM2NjgwMzE4IzIwMjM3MzA=\",\"datePublished\":\"2025-01-07T12:06:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNzQ1OSM2NjgwMzE4IzIwMjM3MzA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNzQ1OSM2NjgwMzE4IzIwMjM3MzA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\/","og_locale":"en_US","og_type":"article","og_title":"ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025 - Market Newsdesk","og_description":"RAMSEY, N.J. and BOCA RATON, Fla., Jan. 07, 2025 (GLOBE NEWSWIRE) &#8212; ADMA Biologics, Inc. (Nasdaq: ADMA) (\u201cADMA\u201d or the \u201cCompany\u201d), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced that Company management will present at the 43rd Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 13-16, 2025. ADMA\u2019s presentation will be on Monday, January 13, 2025, at 10:30 a.m. PT. A live audio webcast of the call will be available under \u201cEvents &amp; Webcasts\u201d in the investor section of the Company\u2019s website, https:\/\/ir.admabiologics.com\/events-webcasts. An archived webcast will be available on the Company\u2019s website approximately two hours after the event. About ADMA Biologics, Inc. (ADMA) ADMA Biologics is an end-to-end &hellip; Continue reading \"ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-01-07T12:06:02+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzQ1OSM2NjgwMzE4IzIwMjM3MzA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025","datePublished":"2025-01-07T12:06:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\/"},"wordCount":375,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzQ1OSM2NjgwMzE4IzIwMjM3MzA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\/","name":"ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzQ1OSM2NjgwMzE4IzIwMjM3MzA=","datePublished":"2025-01-07T12:06:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzQ1OSM2NjgwMzE4IzIwMjM3MzA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzQ1OSM2NjgwMzE4IzIwMjM3MzA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-participate-in-the-j-p-morgan-healthcare-conference-on-january-13-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/798321","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=798321"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/798321\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=798321"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=798321"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=798321"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}